| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |